Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Knightscope, Inc. stock logo
KSCP
Knightscope
$0.33
-7.5%
$0.65
$0.33
▼
$5.96
$11.08M1.381.09 million shs700,243 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$24.70
-4.1%
$19.87
$16.67
▼
$38.11
$1.35B0.881.32 million shs1.04 million shs
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$0.94
-6.7%
$1.09
$0.80
▼
$2.86
$80.43M1.4962,343 shs1.25 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Knightscope, Inc. stock logo
KSCP
Knightscope
-7.32%-20.62%-37.03%-76.55%-93.23%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-4.08%+3.78%+35.19%+13.93%-11.56%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-6.71%+11.74%-5.30%-33.65%-57.94%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Knightscope, Inc. stock logo
KSCP
Knightscope
$0.33
-7.5%
$0.65
$0.33
▼
$5.96
$11.08M1.381.09 million shs700,243 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$24.70
-4.1%
$19.87
$16.67
▼
$38.11
$1.35B0.881.32 million shs1.04 million shs
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$0.94
-6.7%
$1.09
$0.80
▼
$2.86
$80.43M1.4962,343 shs1.25 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Knightscope, Inc. stock logo
KSCP
Knightscope
-7.32%-20.62%-37.03%-76.55%-93.23%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-4.08%+3.78%+35.19%+13.93%-11.56%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-6.71%+11.74%-5.30%-33.65%-57.94%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Knightscope, Inc. stock logo
KSCP
Knightscope
2.50
Moderate Buy$12.673,703.80% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.38
Hold$25.252.23% Upside
Stereotaxis Inc. stock logo
STXS
Stereotaxis
3.00
Buy$2.83200.71% Upside

Current Analyst Ratings Breakdown

Latest STXS, KSCP, and PRCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/11/2026
Stereotaxis Inc. stock logo
STXS
Stereotaxis
Lower Price TargetBuy$3.00 ➝ $2.00
11/6/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Boost Price TargetHold$21.00 ➝ $24.00
11/5/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Boost Price TargetNeutral$20.00 ➝ $21.00
11/5/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Boost Price TargetMarket Perform$20.00 ➝ $22.00
10/16/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
UpgradeStrong-Buy
10/15/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Reiterated RatingSell (E+)
10/6/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Initiated CoverageOverweight$30.00
10/6/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
UpgradeStrong-Buy
9/9/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Reiterated RatingMarket Perform
9/4/2026
Knightscope, Inc. stock logo
KSCP
Knightscope
Reiterated RatingSell (E+)
8/27/2026
Stereotaxis Inc. stock logo
STXS
Stereotaxis
Reiterated RatingOutperform
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Knightscope, Inc. stock logo
KSCP
Knightscope
$11.34M0.69N/AN/A$1.22 per share0.27
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$308.05M4.61N/AN/A$5.72 per share4.32
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$32.38M2.92N/AN/A$0.14 per share6.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Knightscope, Inc. stock logo
KSCP
Knightscope
-$33.81M-$2.95N/AN/AN/A-179.85%-157.74%-90.46%N/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$95.57M-$2.02N/AN/AN/A-32.60%-33.23%-23.58%N/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-$21.64M-$0.28N/AN/AN/A-70.86%-144.02%-35.66%N/A

Latest STXS, KSCP, and PRCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
Knightscope, Inc. stock logo
KSCP
Knightscope
-$0.55-$0.50+$0.05-$0.50$8.85 million$8.68 million
11/10/2026Q3 2026
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-$0.0533-$0.07-$0.0167-$0.0510$9.60 million$8.93 million
11/4/2026Q3 2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.3915-$0.46-$0.0685-$0.46$100.52 million$98.29 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Knightscope, Inc. stock logo
KSCP
Knightscope
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Knightscope, Inc. stock logo
KSCP
Knightscope
0.14
1.18
0.94
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.16
5.89
4.73
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/A
1.42
0.95

Institutional Ownership

CompanyInstitutional Ownership
Knightscope, Inc. stock logo
KSCP
Knightscope
14.61%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
45.35%

Insider Ownership

CompanyInsider Ownership
Knightscope, Inc. stock logo
KSCP
Knightscope
1.75%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
4.00%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
16.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Knightscope, Inc. stock logo
KSCP
Knightscope
40023.33 million22.92 millionNot Optionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
88857.54 million55.24 millionOptionable
Stereotaxis Inc. stock logo
STXS
Stereotaxis
131100.20 million84.14 millionNot Optionable

Recent News About These Companies

Stereotaxis (NYSEAMERICAN:STXS) Director Buys $24,900.00 in Stock
Stereotaxis (NYSEAMERICAN:STXS) Stock Price Target Cut by TD Cowen
Stereotaxis (STXS) Q3 2026 Earnings Call Transcript
What Stereotaxis (STXS) Said on Its Q3 Earnings Call
Stereotaxis Q3 Loss Flat, Revenue Rises; Shares Fall After Hours

New MarketBeat Followers Over Time

Media Sentiment Over Time

Knightscope stock logo

Knightscope NASDAQ:KSCP

$0.33 -0.03 (-7.50%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$0.32 -0.01 (-3.00%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Knightscope, Inc. designs, develops, manufactures, markets, deploys, and supports autonomous security robots (ASR) in the United States. Its products include K3 and K5 ASRs designed to roam a geo-fenced area autonomously by utilizing numerous sensors and lasers, either on a random basis or based on a particular patrolling algorithm to navigate around people, vehicles, and objects in dynamic indoor or outdoor environments; K1, an ASR for used in indoors or outdoors and at ingress/egress points for both people and vehicles; and K7, a multi-terrain ASR. The company also develops and operates the Knightscope security operations center (KSOC), a browser-based interface, which allows real-time data access service to its clients for alert of an abnormal event; and Knightscope network operations center (KNOC), a custom set of tools that enables it to manage and monitor the network of ASRs with alerts related to critical indicators and statistics, including charging, software, navigation, and temperatures, as well as to execute over-the-air software upgrades, patches, and other related items. In addition, it offers Knightscope+, a virtual monitoring and response solution that provides an alternative for client sites. The company serves airports, commercial real estate, corporate campus, homeowner associations, hotels, universities, municipalities, rail, healthcare, public parks, schools, casinos, corporations, logistics, manufacturing, law enforcement, Parking areas, municipalities, universities, and property management companies, as well as the U.S. federal government. Knightscope, Inc. was incorporated in 2013 and is headquartered in Mountain View, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$24.70 -1.05 (-4.08%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$25.46 +0.76 (+3.08%)
As of 11/20/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Stereotaxis stock logo

Stereotaxis NYSEAMERICAN:STXS

$0.94 -0.07 (-6.71%)
Closing price 11/20/2026 04:10 PM Eastern
Extended Trading
$0.97 +0.03 (+3.06%)
As of 11/20/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.